17-7552219-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_172089.4(TNFSF12-TNFSF13):​c.373+1241C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.593 in 151,954 control chromosomes in the GnomAD database, including 27,446 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.59 ( 27446 hom., cov: 33)

Consequence

TNFSF12-TNFSF13
NM_172089.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0710

Publications

27 publications found
Variant links:
Genes affected
TNFSF12 (HGNC:11927): (TNF superfamily member 12) The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine, which exists in both membrane-bound and secreted forms, can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Alternative splicing results in multiple transcript variants. Some transcripts skip the last exon of this gene and continue into the second exon of the neighboring TNFSF13 gene; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
TNFSF12-TNFSF13 (HGNC:33537): (TNFSF12-TNFSF13 readthrough) This gene encodes a member of the tumor necrosis factor superfamily. It encodes a hybrid protein composed of the cytoplasmic and transmembrane domains of family member 12 fused to the C-terminal domain of family member 13. The hybrid protein is membrane anchored and presents the receptor-binding domain of family member 13 at the cell surface. It stimulates cycling in T- and B-lymphoma cell lines. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.676 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_172089.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFSF12
NM_003809.3
MANE Select
c.373+1241C>T
intron
N/ANP_003800.1
TNFSF12-TNFSF13
NM_172089.4
c.373+1241C>T
intron
N/ANP_742086.1
TNFSF12
NR_037146.2
n.469+1241C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFSF12
ENST00000293825.11
TSL:1 MANE Select
c.373+1241C>T
intron
N/AENSP00000293825.6
TNFSF12-TNFSF13
ENST00000293826.4
TSL:1
c.373+1241C>T
intron
N/AENSP00000293826.4
TNFSF12
ENST00000322272.11
TSL:1
n.373+1241C>T
intron
N/AENSP00000314636.7

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
90024
AN:
151836
Hom.:
27421
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.453
Gnomad AMI
AF:
0.604
Gnomad AMR
AF:
0.564
Gnomad ASJ
AF:
0.735
Gnomad EAS
AF:
0.668
Gnomad SAS
AF:
0.694
Gnomad FIN
AF:
0.653
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.654
Gnomad OTH
AF:
0.604
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.593
AC:
90094
AN:
151954
Hom.:
27446
Cov.:
33
AF XY:
0.596
AC XY:
44277
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.454
AC:
18770
AN:
41382
American (AMR)
AF:
0.564
AC:
8615
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.735
AC:
2552
AN:
3472
East Asian (EAS)
AF:
0.668
AC:
3454
AN:
5168
South Asian (SAS)
AF:
0.696
AC:
3357
AN:
4826
European-Finnish (FIN)
AF:
0.653
AC:
6889
AN:
10542
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.654
AC:
44435
AN:
67972
Other (OTH)
AF:
0.602
AC:
1271
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1811
3621
5432
7242
9053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.637
Hom.:
116570
Bravo
AF:
0.582
Asia WGS
AF:
0.637
AC:
2217
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
5.0
DANN
Benign
0.86
PhyloP100
0.071
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4511593; hg19: chr17-7455536; COSMIC: COSV53433869; API